ID   EC109/Taxol
AC   CVCL_T047
DR   Wikidata; Q54831911
RX   PubMed=24002547;
CC   Population: Chinese.
CC   Doubling time: 31.3 +- 0.39 hours (PubMed=24002547).
CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6898 ! Eca-109
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 11
//
RX   PubMed=24002547; DOI=10.3892/ijo.2013.2083;
RA   Wang C., Guo L.-B., Ma J.-Y., Li Y.-M., Liu H.-M.;
RT   "Establishment and characterization of a paclitaxel-resistant human
RT   esophageal carcinoma cell line.";
RL   Int. J. Oncol. 43:1607-1617(2013).
//